专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

91. 发明申请

WO1994020334A1 FILTER CLOTH FOR AIR BAG 审中-公开
标题翻译：空气袋过滤衣
公开(公告)号：WO1994020334A1
公开(公告)日：1994-09-15
申请号：PCT/JP1994000343
申请日：1994-03-03
申请人： TEIJIN LIMITED , NISHIMURA, Kunio , KUMAKAWA, Shiro , NAKAGAWA, Hideo
发明人： TEIJIN LIMITED
IPC分类号： B60R21/28
CPC分类号： B60R21/235 , B01D39/083 , B01D2239/0478 , B01D2239/0613 , B01D2239/1216 , B01D2239/1233 , B01D2239/1258 , B01D2239/1291 , B60R21/239 , D03D1/02 , Y10T428/24273 , Y10T442/3195
摘要： This cloth consists of a textile of synthetic fiber, having (1) a base texture of single plain woven or twill-fabric structure, and (2) a plurality of textures having a higher air permeability than that of the base texture, and including: a) a silky-woven texture having pin holes; b) a double plain-woven texture; or c) a double twill-woven texture. When an air bag is manufactured by using this cloth, it is possible to freely lay out a cutting and set cutting portions. Also, in inflating the air bag, it is possible to flow out part of the inflation gas instantaneously in order to ensure the safety of the crew.
摘要翻译：这种布由合成纤维织物组成，其具有（1）单一平纹织物或斜纹织物结构的基部织构，和（2）具有比基底织构更高的透气性的多个纹理，并且包括： a）具有针孔的丝般织造纹理; b）双重平纹织构; 或c）双重斜纹纹理。当使用这种布制造气囊时，可以自由地布置切割和切割部分。此外，在使气囊膨胀时，可以瞬间流出部分膨胀气体，以确保船员的安全。

92. 发明申请

WO1994017804A1 PHARMACEUTICAL COMPOSITION FOR TREATING CEREBRAL THROMBOSIS 审中-公开
标题翻译：用于治疗脑膜炎的药物组合物
公开(公告)号：WO1994017804A1
公开(公告)日：1994-08-18
申请号：PCT/JP1994000142
申请日：1994-02-02
申请人： TEIJIN LIMITED , TAISHO PHARMACEUTICAL CO., LTD. , MIZUSHIMA, Yutaka , BANNAI, Kiyoshi , NAKAYAMA, Shigeru
发明人： TEIJIN LIMITED , TAISHO PHARMACEUTICAL CO., LTD.
IPC分类号： A61K31/557
CPC分类号： C07J71/0005 , A61K9/1075 , A61K31/557
摘要： A pharmaceutical composition for treating cerebral thrombosis, which is an emulsion comprising 0.2-1,000 mu g, per milliliter of the composition, of an isocarbacyclin represented by general formula (1), 0.05-0.5 g, per milliliter of the composition, of a vegetable oil, 0.01-0.5 g, per gram of the oil, of a phospholipid, and water; and a method of treating cerebral thrombosis with the same, wherein R represents hydrogen or C1-C10 alkyl; and R represents optionally substituted C1-C13 alkyl, optionally substituted C2-C13 alkenyl or alkynyl, or optionally substituted C3-C10 cycloalkyl.
摘要翻译：一种用于治疗脑血栓形成的药物组合物，其为每毫升组合物0.2-1,000μg的由通式（1）表示的异卡巴环素，每毫升组合物0.05-0.5g的植物，植物油，0.01-0.5g，每克油，磷脂和水; 以及用其治疗脑血栓形成的方法，其中R 1表示氢或C 1 -C 10烷基; R 2表示任选取代的C 1 -C 13烷基，任选取代的C 2 -C 13烯基或炔基，或任选取代的C 3 -C 10环烷基。

93. 发明申请

WO1994011439A1 FLAME-RETARDANT POLYESTER RESIN COMPOSITION 审中-公开
标题翻译：阻燃聚酯树脂组合物
公开(公告)号：WO1994011439A1
公开(公告)日：1994-05-26
申请号：PCT/JP1993001635
申请日：1993-11-10
申请人： TEIJIN LIMITED , YOSHIMURA, Mie , OGAWA, Yoshinari , SHIMOTSUMA, Sakae
发明人： TEIJIN LIMITED
IPC分类号： C08L67/02
CPC分类号： C08L67/02 , C08L33/00 , C08L2666/04
摘要： A composition mainly comprising polybutylene terephthalate, and also containing a halobenzyl acrylate resin having repeated halobenzyl acrylate or methacrylate units and phosphonic acid or a monoester thereof. The composition may further contain a polytetrafluoroethylene resin, an ethylene copolymer and an inorganic filler as optional components. The composition is capable of a reduction in the amount of volatile decomposition gas generated in the melt molding step and an improvement in the fluidity, thus shortening the cycle of producing molded articles.
摘要翻译：主要包括聚对苯二甲酸丁二醇酯的组合物，还包含具有重复的卤代苄基丙烯酸酯或甲基丙烯酸酯单元的卤代苄基丙烯酸酯树脂和膦酸或其单酯。组合物还可以含有聚四氟乙烯树脂，乙烯共聚物和无机填料作为任选组分。该组合物能够减少在熔融模塑步骤中产生的挥发性分解气体的量和流动性的改善，从而缩短生产模塑制品的循环。

94. 发明申请

WO1993014152A1 POLYESTER FILM FOR METAL SHEET LAMINATION AND USE THEREOF 审中-公开
标题翻译：用于金属片层压的聚酯薄膜及其用途
公开(公告)号：WO1993014152A1
公开(公告)日：1993-07-22
申请号：PCT/JP1993000041
申请日：1993-01-14
申请人： TEIJIN LIMITED , HASEGAWA, Kinji , ASAI, Takeo , MURAKAMI, Yoji
发明人： TEIJIN LIMITED
IPC分类号： C08J05/18
CPC分类号： B32B15/09 , B29C55/12 , B29K2067/00 , B29K2105/16 , B32B1/02 , B32B3/26 , B32B3/30 , B32B15/08 , B32B27/36 , B32B2307/718 , B32B2307/72 , B32B2307/736 , C08J5/18 , C08J2367/02 , C08L67/02 , Y10T428/31681 , C08L2666/18
摘要： A polyester film excellent in the workability for can manufacture, such as lamination with metal sheet and deep drawing, and suitable for manufacturing a metallic can excellent in heat and impact resistances and flavor retention. The film is produced from a mixture consisting of 99-60 wt.% of a copolyester (A) mainly comprising repeating ethylene terephthalate units and having a melting point of 210-245 °C and 1-40 wt. % of polybutylene terephthalate or a copolyester (B) mainly comprising repeating butylene terephthalate units and having a melting point of 180-223 °C. The film contains a slip additive having a mean particle diameter of 2.5 νm or less and has a coefficient of plane orientation of 0.08 to 0.16, a thermal shrinkage of 10 % or less at 150 °C and a density of less than 1.385 g/cm3.

95. 发明申请

WO1992013079A1 HUMAN PROTEIN C EXPRESSION VECTOR 审中-公开
标题翻译：人类蛋白C表达载体
公开(公告)号：WO1992013079A1
公开(公告)日：1992-08-06
申请号：PCT/JP1992000070
申请日：1992-01-28
申请人： TEIJIN LIMITED
发明人： TEIJIN LIMITED , SUZUKI, Masahiko , WAKABAYASHI, Kenji , TAKAZAWA, Yoshiharu , SUMI, Yoshihiko
IPC分类号： C12N15/57
CPC分类号： C12N9/6464 , C12N15/67 , C12Y304/21069
摘要： An object of the present invention is to provide DNA fragments encoding human protein C and human protein C expression vectors including the same. The object is attained by removing arbitrary n (n = 1 to 6) introns from 7 introns distributing between 8 exons in human protein C gene, ligating the remaining before and behind sequences to form novel DNA fragments encoding human protein C and preparing expression vectors including the same and mammalian cells transformed with said vectors. Another object of the present invention is to provide DNA fragments of increased expression efficiency by incorporating a useful DNA fragment into the introns remaining in the DNA fragments. They are useful for production of human protein C.
摘要翻译：本发明的目的是提供编码人蛋白C的DNA片段和包含该蛋白质的人蛋白C表达载体。目的是通过从人蛋白C基因中8个外显子之间分布的7个内含子中去除任意n（n = 1至6）内含子，连接剩余的序列之前和之后，形成编码人蛋白C的新型DNA片段，并制备表达载体，包括用所述载体转化的相同和哺乳动物细胞。本发明的另一个目的是通过将有用的DNA片段并入到残留在DNA片段中的内含子中来提供增加的表达效率的DNA片段。它们可用于生产人类蛋白质C.

96. 发明申请

WO1992006377A1 METHOD AND KIT FOR IMMUNOASSAY OF PROPEPTIDE OF OSTEOCALCIN AND PROOSTEOCALCIN 审中-公开
标题翻译：用于免疫球蛋白和蛋白质的方法和试剂盒
公开(公告)号：WO1992006377A1
公开(公告)日：1992-04-16
申请号：PCT/JP1991001330
申请日：1991-10-03
申请人： TEIJIN LIMITED , HOSODA, Kenji , HONDA, Hitomi , KUBOTA, Takaharu , NAKAMOTO, Tadakatsu
发明人： TEIJIN LIMITED
IPC分类号： G01N33/53
CPC分类号： G01N33/74 , C07K14/78 , C07K16/18 , G01N33/6887
摘要： (i) A method for the immunoassay of the propeptide of osteocalcin present in a specimen by the sandwich method, wherein an antibody which specifically recognizes said propeptide is used as an antibody (first antibody) combined with an insoluble carrier and a labelled antibody (second antibody), and a kit therefor; (ii) a method for the immunoassay of proosteocalcin present in a specimen by the sandwich method, wherein one of an antibody (first antibody) combined with an insoluble carrier and a labelled antibody (second antibody) is an antibody which specifically recognizes the propeptide of osteocalcin, while the other is an antibody which specifically recognizes osteocalcin, and a kit therefor; and (iii) a method for the immunoassay of the total content of the propeptide of osteocalcin and proosteocalcin in a specimen by the competitive method, wherein an antibody which specifically recognizes the propeptide of osteocalcin is used as an antibody which combines with an insoluble carrier or which can be insolubilized.

97. 发明申请

WO1991016284A1 PROCESS FOR PRODUCING ALKENYLBENZENE AND DERIVATIVE THEREOF 审中-公开
标题翻译：生产亚苄基苯及其衍生物的方法
公开(公告)号：WO1991016284A1
公开(公告)日：1991-10-31
申请号：PCT/JP1991000542
申请日：1991-04-23
申请人： TEIJIN LIMITED , SHIMADA, Keizo , SUMITANI, Koji , ITOH, Seiji
发明人： TEIJIN LIMITED
IPC分类号： C07C02/72
CPC分类号： B01J23/04 , C07C2/72 , C07C2523/04 , C07C15/44
摘要： A process for producing efficiently alkenylbenzene, which comprises reacting alkylbenzene with 1,3-butadiene in the presence of a catalyst prepared by the dispersion treatment of an alkali metal with an inorganic potassium salt in the substantial absence of oxygen and water.
摘要翻译：一种有效生产烯基苯的方法，其包括在基本上不存在氧和水的情况下通过碱金属与无机钾盐的分散处理制备的催化剂的存在下使烷基苯与1,3-丁二烯反应。

98. 发明申请

WO1991016044A1 PLASTER 审中-公开
标题翻译：石膏
公开(公告)号：WO1991016044A1
公开(公告)日：1991-10-31
申请号：PCT/JP1991000541
申请日：1991-04-23
申请人： TEYSAN PHARMACEUTICALS CO., LTD. , TEIJIN LIMITED , HIDAKA, Osafumi , MURAKAMI, Satoshi
发明人： TEYSAN PHARMACEUTICALS CO., LTD. , TEIJIN LIMITED
IPC分类号： A61K09/70
CPC分类号： A61K9/703 , A61F13/00063 , A61F13/0206 , A61F13/0223 , A61F13/0226 , A61F13/023 , A61F13/0253 , A61F13/0256 , A61F2013/00663 , A61F2013/00868 , A61F2013/00906 , A61K9/7061 , A61K9/7084
摘要： A plaster consisting of a film layer formed of a film wherein the thickness thereof is 0.5 - 4.9 mu m, the strengths in two directions intersecting substantially perpendicularly are 8 - 85 g/mm, respectively, the elongations in two directions intersecting substantially perpendicularly are 30 - 150 %, respectively, and, an elongation ratio of one direction to the other is 1.5 - 5.0 (provided that, when the elongations in the two directions are not equal, a smaller elongation is used as a denominator) and an adhesive layer (a) formed of an adhesive agent containing a percutaneous absorptive pharmaceutical, laminated on one of the surfaces of the film layer and having a thickness of 2 - 60 mu m. The possibility of skin poisoning is decreased and a pharmaceutical of a clinically effective amount can be percutaneously absorbed. Further, it is preferable to provide a layer such as a planar support member. For example, a plaster consisting of the film layer (3) and the adhesive layer (4), wherein a planar support member (1) and a peelable film (5) are further laminated through an adhesive layer (b) (2), is excellent to handle.
摘要翻译：由厚度为0.5-4.9μm的膜形成的薄膜层，基本上垂直相交的两个方向的强度分别为8〜85g / mm 2，两个方向上大致垂直相交的伸长率为30 - 150％，并且一个方向相对于另一个方向的伸长率为1.5-5.0（条件是当两个方向上的伸长率不相等时，使用较小的伸长率作为分母）和粘合剂层 a）由含有经皮吸收药物的粘合剂形成，层压在膜层的一个表面上，厚度为2-60μm。皮肤中毒的可能性降低，可以经皮吸收临床有效量的药物。此外，优选地，提供诸如平面支撑构件的层。例如，通过粘合剂层（b）（2）进一步层压由薄膜层（3）和粘合剂层（4）组成的石膏，其中平面支撑构件（1）和可剥离薄膜（5）非常好处理。

99. 发明申请

WO1991001999A1 PHOSPHOLIPASE A2 INHIBITING PROTEIN ORIGINATING IN INFLAMED REGION, PRODUCTION THEREOF, AND GENE THEREFOR 审中-公开
标题翻译：磷脂酶A2抑制蛋白质在炎症区域中的产生，其生产及其基因
公开(公告)号：WO1991001999A1
公开(公告)日：1991-02-21
申请号：PCT/JP1990000996
申请日：1990-08-03
申请人： TEIJIN LIMITED , SUWA, Yorimasa , IMAIZUMI, Atsushi , OKADA, Masahiro , KUDO, Ichiro , INOUE, Keizo , SUZUKI, Yoji
发明人： TEIJIN LIMITED
IPC分类号： C07K13/00
CPC分类号： C07K14/4703 , A61K38/00
摘要： A phospholipase A2 inhibiting protein originating in inflamed regions and having a sequence of 334 amino acids as shown or a physiologically equivalent amino acid sequence, a method of producing said protein by enzymatically treating the serum of a mammal, and a gene which codes for said protein.

100. 发明申请

WO1990010014A1 NEW VITAMIN B12 DERIVATIVE, PRODUCTION THEREOF, AND APPLICATION THEREOF 审中-公开
标题翻译：新维生素B12衍生物，其生产方法及其应用
公开(公告)号：WO1990010014A1
公开(公告)日：1990-09-07
申请号：PCT/JP1990000253
申请日：1990-02-28
申请人： TEIJIN LIMITED , TORAYA, Tetsuo , ISHIDA, Atsuhiko , UEJIMA, Yasuhide , FUJII, Katsuhiko
发明人： TEIJIN LIMITED
IPC分类号： C07H23/00
CPC分类号： C07H23/00 , C07F15/065
摘要： A vitamin B12 derivative of formula (I) and salts thereof, wherein L represents a ligand bound to the cobalt atom of the corrin ring, B represents a base having a heterocyclic structure, and R represents an (un)substituted hydrocarbon group.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式